MedTrace Logo

Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism

NCT05173116 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-01-11

No results posted yet for this study

Summary

The study was designed to evaluate the APIVIGIE program use at CH d'Arras. The objective of this program is to reduce repeated visits by the same patient to the emergency room for Alcoholism Severe Paroxysmal

Conditions

  • Intoxication;Alcohol;Acute
  • Emergencies

Interventions

OTHER

Medical Outcomes Study Short Form 36 (SF 36)

completion of questionnaire quality of life SF 36 (inclusion, Month 3, Month 6).

OTHER

observationnal study

data collection

Sponsors & Collaborators

  • F2RSM Psy (Hauts-de-France Regional Federation for Research in Psychiatry and Mental Health)

    collaborator UNKNOWN

  • Centre Hospitalier Arras

    lead OTHER

Principal Investigators

  • Dominique LEJEUNE, M.D · Centre Hospitalier Arras

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2023-02-28
Completion
2023-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05173116 on ClinicalTrials.gov